Drinking coffee can reduce the risk of basal cell cancer

According to recent foreign media reports, a new study announced at the 10th International Conference on Frontier areas of Cancer Prevention and treatment, sponsored by the American Association for Cancer Research (AACR), found that drinking coffee can reduce the risk of basal cell carcinoma (BCC, one of the most common types of skin cancer, also known as basal cell epithelioma).

This prospective study examined the association between coffee drinking and the risk of basal cell carcinoma, squamous cell carcinoma (SCC) and melanoma. It turns out that drinking coffee can only reduce the risk of basal cell cancer. "our new research shows that drinking coffee is an important measure to prevent basal cell cancer," said Song Fengju, a postdoctoral fellow and lead researcher in dermatology at Harvard Medical School. "

A study by Dr. Song and his colleagues found that coffee consumption was inversely proportional to the risk of skin cancer. Men and women who drank more than three cups of coffee a day had a 9% and 20% lower risk of basal cell cancer, respectively, compared with those who drank less than one cup of coffee a month. However, drinking coffee does not reduce the risk of the other two types of skin cancer (squamous cell carcinoma and melanoma). The researchers pointed out that caffeine in coffee is likely to play a protective role. Non-caffeinated coffee was not associated with a reduced risk of basal cell cancer.